debrisoquin and guanethidine
debrisoquin has been researched along with guanethidine in 30 studies
Research
Studies (30)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (83.33) | 18.7374 |
1990's | 1 (3.33) | 18.2507 |
2000's | 2 (6.67) | 29.6817 |
2010's | 2 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Petrie, JC | 1 |
Talbot, S | 1 |
Goldberg, AD; Raftery, EB | 1 |
Smith, AJ; Talbot, S | 1 |
Smith, AJ | 1 |
Burnstock, G | 1 |
Akinkugbe, OO; Basile, U; Carlisle, R; Solagbade, ME | 1 |
Gill, GW; Talbot, S | 1 |
Adi, FC; Anwunah, A; Eze, CJ | 1 |
Bing, RH; O'Malley, BC; Talbot, S | 1 |
Erdtmansky, P; Goehl, TJ | 1 |
Aloe, L; Johnson, EM | 1 |
Almeyda, J; Levantine, A | 1 |
Simpson, FO | 1 |
Antonaccio, MJ | 1 |
Bounameaux, Y | 1 |
Hamilton, M | 1 |
Palkoski, Z; Pettinger, W; Renyi, E; Sheppard, H | 1 |
Laverty, R | 1 |
Abbs, ET; Dodd, MG | 1 |
Bauer, GE; Ewan, CE; Garrick, R; Neale, FC | 1 |
Gulati, OD; Prasad, CM; Shah, DS | 1 |
Muldowney, FP | 1 |
Mayor, D; Tomlinson, DR | 1 |
Fleminger, R; Paykel, ES; Watson, JP | 1 |
Bedair, MM; Galal, SM; Gazy, AA; Wahbi, AA | 1 |
Reviews
5 review(s) available for debrisoquin and guanethidine
Article | Year |
---|---|
Morphological changes produced by drugs acting on the autonomic nervous system.
Topics: 5,6-Dihydroxytryptamine; 5,7-Dihydroxytryptamine; Animals; Antihypertensive Agents; Autonomic Nervous System; Bretylium Compounds; Debrisoquin; Guanethidine; Guanidines; Hydroxydopamines; Nervous System Diseases; Picolines; Reserpine | 1979 |
Cutaneous reactions to cardiovascular drugs.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Debrisoquin; Digitalis Glycosides; Drug Eruptions; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Mercury; Methyldopa; Nitroglycerin; Pentaerythritol Tetranitrate; Procainamide; Quinidine; Thiazines | 1973 |
Combination antihypertensive therapy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amphetamine; Antidepressive Agents; Antihypertensive Agents; Benzothiadiazines; Clonidine; Debrisoquin; Diuretics; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Monoamine Oxidase Inhibitors; Phenylbutazone; Phytotherapy; Plants, Medicinal; Potassium Chloride; Rauwolfia; Reserpine; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; Spironolactone; Sympathomimetics; Triamterene | 1971 |
The mechanisms of action of some antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Brain; Bretylium Compounds; Clonidine; Debrisoquin; Diuretics; Guanethidine; Heart Rate; Humans; Hydralazine; Hypertension; Methyldopa; Neurons; Normetanephrine; Propranolol; Receptors, Adrenergic; Synaptic Transmission | 1973 |
Psychiatric side effects of antihypertensive drugs other than reserpine.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Anxiety; Bethanidine; Clonidine; Debrisoquin; Depression; Dreams; Drug Interactions; Female; Ganglionic Blockers; Guanethidine; Hallucinations; Humans; Hydralazine; Hypotension; Male; Mental Disorders; Mental Processes; Methyldopa; Propranolol; Psychotropic Drugs; Sleep; Veratrum Alkaloids | 1982 |
Trials
3 trial(s) available for debrisoquin and guanethidine
Article | Year |
---|---|
An approach to realistic evaluation of antihypertensive regimes.
Topics: Adult; Antihypertensive Agents; Community Medicine; Debrisoquin; Female; Guanethidine; Humans; Hypertension; Male; Methyldopa; Middle Aged; Nigeria; Research Design; Socioeconomic Factors | 1977 |
Comparison of debrisoquine and guanethidine in treatment of hypertension.
Topics: Administration, Oral; Adult; Body Weight; Chronic Disease; Debrisoquin; Economics, Medical; Ejaculation; Female; Guanethidine; Humans; Hypertension; Isoquinolines; Libido; Male; Middle Aged; Surveys and Questionnaires; Time Factors | 1975 |
Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.
Topics: Antihypertensive Agents; Bethanidine; Debrisoquin; Diarrhea; Guanethidine; Guanidines; Humans; Hypertension; Hypotension; Isoquinolines; Physical Exertion | 1975 |
Other Studies
22 other study(ies) available for debrisoquin and guanethidine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Diseases of the cardiovascular system Hypertension--II.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bethanidine; Clonidine; Debrisoquin; Diazoxide; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Methyldopa; Phytotherapy; Piperazines; Plants, Medicinal; Quinazolines; Rauwolfia | 1976 |
Angina in hypertensive patients. With particular reference to the negative chronotropic effects of sympatholytic therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bethanidine; Blood Pressure; Debrisoquin; Drug Therapy, Combination; Guanethidine; Heart Rate; Humans; Hypertension; Male; Methyldopa; Oxprenolol; Physical Exertion; Propranolol; Sympatholytics | 1976 |
Patterns of blood-pressure during chronic administration of postganglionic sympathetic blocking drugs for hypertension.
Topics: Adult; Aged; Bethanidine; Blood Pressure; Circadian Rhythm; Debrisoquin; Female; Guanethidine; Guanidines; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Isoquinolines; Male; Middle Aged; Physical Exertion; Pulse; Rest | 1976 |
Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure.
Topics: Bethanidine; Cardiomegaly; Circadian Rhythm; Debrisoquin; Female; Guanethidine; Guanidines; Heart Rate; Humans; Hypertension; Hypotension; Hypotension, Orthostatic; Isoquinolines; Male; Middle Aged; Physical Exertion; Sex Factors; Time Factors; Urea | 1975 |
Management of hypertension.
Topics: Adrenergic beta-Antagonists; Age Factors; Bethanidine; Clonidine; Debrisoquin; Decision Making; Diuretics; Female; Guanethidine; Humans; Hypertension; Male; Methyldopa; Pregnancy | 1975 |
Exertional hypotension due to postganglionic sympathetic blocking drugs.
Topics: Bethanidine; Blood Pressure; Debrisoquin; Guanethidine; Guanidines; Heart Rate; Humans; Hypotension, Orthostatic; Isoquinolines; Physical Exertion | 1976 |
Gas-liquid chromatographic electron capture determination of some monosubstituted guanido-containing drugs.
Topics: Chromatography, Gas; Debrisoquin; Guanethidine; Guanidines; Humans; Isoquinolines | 1975 |
Suppression of the in vitro and in vivo cytotoxic effects of guanethidine in sympathetic neurons by nerve growth factor.
Topics: Adrenergic Agents; Animals; Animals, Newborn; Debrisoquin; Ganglia, Autonomic; Ganglia, Spinal; Guanethidine; Hydrogen-Ion Concentration; Microscopy, Electron; Microtubules; Mitochondrial Swelling; Nerve Growth Factors; Organ Culture Techniques; Rats; Sympathetic Nervous System | 1974 |
Paradoxical vagal tachycardia in ganglion-blocked anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Atropine; Blood Pressure; Bretylium Compounds; Chlorisondamine; Debrisoquin; Desipramine; Dogs; Drug Interactions; Electric Stimulation; Female; Ganglionic Blockers; Guanethidine; Heart Rate; Hexamethonium Compounds; Male; Mecamylamine; Methylphenidate; Oxprenolol; Reserpine; Vagus Nerve | 1974 |
[Studies on the effect of various substances on platelet function with several methods].
Topics: Amphetamine; Anti-Anxiety Agents; Blood Platelets; Caffeine; Chlorpromazine; Debrisoquin; Dibenzazepines; Flurazepam; Guanethidine; Humans; Oxazoles; Papaverine; Phenytoin; Platelet Aggregation; Pyridines; Theophylline | 1973 |
Hypertension.
Topics: Adrenergic beta-Antagonists; Aortic Diseases; Benzothiadiazines; Brain Diseases; Cerebrovascular Disorders; Cushing Syndrome; Debrisoquin; Diabetes Mellitus; Diuretics; Guanethidine; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypokalemia; Kidney Diseases; Methyldopa; Pulmonary Edema; Sodium Chloride Symporter Inhibitors | 1974 |
Angiotensin antagonism and antihypertensive activity of phosphodiesterase inhibiting agents.
Topics: Adult; Angiotensin II; Animals; Bethanechol Compounds; Blood Pressure; Bradykinin; Bretylium Compounds; Debrisoquin; Diazoxide; Dose-Response Relationship, Drug; Female; Guanethidine; Heart Rate; Humans; Hydralazine; Imidazoles; Male; Norepinephrine; Phenoxybenzamine; Phentolamine; Phosphodiesterase Inhibitors; Rats; Theophylline; Vasodilator Agents | 1973 |
The relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives.
Topics: Animals; Cats; Debrisoquin; Dextroamphetamine; DNA; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guanethidine; Guanidines; In Vitro Techniques; Male; Microsomes; Mitochondria; Neurons; Norepinephrine; Phosphorus; Spleen; Subcellular Fractions; Sympathetic Nervous System; Sympatholytics; Time Factors | 1974 |
Serum uric acid in normal and hypertensive Australian subjects.
Topics: Adolescent; Adult; Age Factors; Australia; Child; Colorimetry; Debrisoquin; Female; Guanethidine; Humans; Hypercholesterolemia; Hypertension; Hypertension, Renal; Kidney Failure, Chronic; Male; Metabolic Diseases; Methyldopa; Middle Aged; Sympatholytics; Uric Acid | 1972 |
Some factors affecting the neuron blocking action of guanethidine, xylocholine, bretylium and debrisoquin.
Topics: Animals; Antihypertensive Agents; Bretylium Compounds; Choline; Debrisoquin; Ethers; Guanethidine; Guinea Pigs; In Vitro Techniques; Isoquinolines; Male; Neurons; Norepinephrine; Sympathetic Nervous System; Sympatholytics; Xylenes | 1973 |
Management of severe hypertension.
Topics: Chlorthalidone; Coma; Debrisoquin; Diazoxide; Guanethidine; Humans; Hypertension, Malignant; Methyldopa; Nephrectomy; Pentolinium Tartrate; Renal Dialysis; Vomiting | 1972 |
The effects of guanethidine, bretylium and debrisoquine on the accumulation of noradrenaline in constricted postganglionic sympathetic nerves in vitro.
Topics: Animals; Antihypertensive Agents; Bretylium Compounds; Cats; Debrisoquin; Ganglia, Autonomic; Guanethidine; In Vitro Techniques; Isoquinolines; Ligation; Microscopy, Electron; Monoamine Oxidase Inhibitors; Nerve Endings; Neurons; Norepinephrine; Sympathetic Nervous System; Time Factors | 1973 |
Spectrophotometric analysis of some guanidino drugs by acid-dye and charge-transfer complexation methods.
Topics: Bromcresol Purple; Debrisoquin; Fluorescent Dyes; Guanethidine; Guanfacine; Guanidines; Hydrogen-Ion Concentration; Ligands; Spectrophotometry, Ultraviolet | 1993 |